Itamar Medical Announces that Publication on the Role of Obstructive Sleep Apnea in Atrial Fibrillation Selected for Inclusion in Circulation’s 2018 Year in Review

Itamar Medical Ltd. (TASE: ITMR), a company that develops, manufactures, and markets non-invasive diagnostic medical devices for sleep apnea with a focus on the cardiology market, today announced that an article previously published in Circulation1 has been selected for inclusion in the journal’s 2018 Year in Review. This review, which appears in the February 2019 issue of Circulation: Arrhythmia and Electrophysiology, comprises the most important and prominent articles of 2018, as determined by the journal’s editors.

Site by Imaginet
Site by Imaginet

Accessibility Toolbar